Full-Time

Engineer I/II

Prime Medicine

Prime Medicine

201-500 employees

Gene editing biotechnology company

Biotechnology

Mid, Senior

Cambridge, MA, USA

Required Skills
Python
Java
C/C++
Requirements
  • BS + 5 years/MS + 3 years in Biology or Engineering disciplines
  • Experience in plate-based assay development, with emphasis on mix-and-read, ELISA, and cell-based assays
  • Experience in lab automation, including liquid handlers (Tecan, Hamilton, Dynamic Devices, etc), scheduling software (Cellario, Genera, Green Button Go), and robotic arms (Precise, KX-2)
  • Programming proficiency (.NET, C++, C#, python, java)
  • Strong collaborator with cross-functional teams and external partners
  • Excellent communication and presentation skills, capable of conveying technical information in a clear and thorough manner
  • Highly self-motivated, driven, can-do, make it happen attitude with ability to own and drive projects
  • Capable of continuous learning, open-minded, curious, highly organized, and detail-oriented
Responsibilities
  • Design, integrate, and program automation systems
  • Design, develop, and automate plate-based (ELISA, Cell-based, mix and read) assays
  • Run and qualify assays
  • Integrate workflows with ELN and LIMS to support scalability and flexibility
  • Identify bottlenecks impeding the team, and proactively implement solutions
  • Work with scientists to understand current workflows, assay design, and automation needs
  • Identify metrics to be collected from workflows, and creation of system for metrics collection, visualization, and reporting in order to identify improvement areas
  • Continually look for new or improved technologies to evaluate for increasing capacity or optimization
  • Work with instrument vendors and external contractors to evaluate, design, and implement new solutions

Prime Medicine's mission is to transform the lives of patients with debilitating diseases through the application of our groundbreaking Prime Editing platform and technology. The company uses Prime Editing, a next-generation gene editing approach that they believe can address the genetic cause of disease and potentially provide patients with long-lasting cures.

Company Stage

N/A

Total Funding

$596M

Headquarters

Cambridge, Massachusetts

Founded

2019

Growth & Insights
Headcount

6 month growth

4%

1 year growth

31%

2 year growth

150%
INACTIVE